Abstract

Review Article

Surgery and new Pharmacological strategy in some atherosclerotic chronic and acute conditions

Luisetto M*, Nili-Ahmadabadi B and Ghulam Rasool Mashori

Published: 18 August, 2017 | Volume 1 - Issue 1 | Pages: 042-048

Introduction

In actual pharmacological therapy we can see that some drugs can be added to other medical instruments to improve their activity: in example we can see medicated stent for some coronary disease, or hormonal medical devices used in pregnancy prevention, but other example are known today. In example Carmustine wafer is delivered by delivery systems in some brain cancer and radioactive seed implants in prostatic cancer. Ocular intra vitreal implants for some macular degenerations (MABS or cortisones) other implants delivery systems drugs, naltrexone implant for opiate dependence. Other strategies imply carrier use to deliver the drugs in the site of action: In example MABS linked to radioactive isotopes in some relapse of severe Hodgkin disease but many other example we can see in therapy used today. So we can think that other chronic conditions can be treated using a combination of drugs with other instrument to improve the clinical outcomes. This to make possible that the ERLICH MUGIC BULLETS can act in the right site reducing the side effect. In example today we can see various medical interventional radiological strategy to treat in coronary and hearth disease with medicate stents positioning or to local use of contrast agents or other valvle surgery procedures with global good clinical results.

Read Full Article HTML DOI: 10.29328/journal.ascr.1001006 Cite this Article Read Full Article PDF

Keywords:

Surgery; Atherosclerotic disease; Pharmacology; Drug delivery systems; Cardiology; Cardiac surgery; CHOF

References

  1. Nakahara T, Dweck MR, Narula N, Pisapia D, Narula J, et al. Coronary Artery Calcification: From Mechanism to Molecular Imaging. JACC Cardiovasc Imaging. 2017; 10: 582-593. Ref.: https://goo.gl/jDdACD
  2. Römer TJ, Brennan JF, Puppels GJ, Zwinderman AH, van Duinen SG, et al. Intravascular ultrasound combined with Raman spectroscopy to localize and quantify cholesterol and calcium salts in atherosclerotic coronary arteries. Arterioscler Thromb Vasc Biol. 2000; 20: 478-483. Ref.: https://goo.gl/VzXgbw
  3. Ranade VV. Drug delivery systems. 4. Implants in drug delivery. J Clin Pharmacol. 1990; 30: 871-889. Ref.: https://goo.gl/bcaszv
  4. Zhou H, Hernandez C, Goss M, Gawlik A, Exner AA. Biomedical Imaging in Implantable Drug Delivery Systems. Curr Drug Targets. 2015; 16: 672-682. Ref.: https://goo.gl/Hxup88
  5. Maniscalco BS, Taylor KA. Calcification in coronary artery disease can be reversed by EDTA-tetracycline long-term chemotherapy. 2004; 11: 95-101. Ref.: https://goo.gl/GRwvzW
  6. Lamas GA, FACC MD, Ian Ergui BS, Omar M Issa. Chelation Therapy for CAD. DO Expert Analysis. 2016. Ref.: https://goo.gl/WP8UWY
  7. Avila MD, Escolar E, Lamas GA. Chelation therapy after the Trial to Assess Chelation Therapy: results of a unique trial. Curr Opin Cardiol. 2014; 29: 481-488. Ref.: https://goo.gl/TehvBS
  8. Luisetto M, Nili-Ahmadabadi B. The Clinical Pharmacist Competence as Pharmaceutical Drug Design Tool. Research & Reviews: Journal of Hospital and Clinical Pharmacy. 2017; 3: 1-2. Ref.: https://goo.gl/D1sptg
  9. Ernst E. Chelation therapy for coronary heart disease: An overview of all clinical investigations. Am Heart J. 2000; 140: 139-141. Ref.: https://goo.gl/QYK9vn
  10. Avila MD, Escolar E, Lamas GA. Chelation therapy after the Trial to Assess Chelation Therapy: results of a unique trial. Curr Opin Cardiol. 2014; 29: 481-488. Ref.: https://goo.gl/Vk9bkr
  11. King SB, Marshall JJ, Tummala PE. Revascularization for coronary artery disease: stents versus bypass surgery. Annu Rev Med. 2010; 61: 199-213. Ref.: https://goo.gl/uhUc2d

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More